Rapporteur








télécharger 1.24 Mb.
titreRapporteur
page22/22
date de publication24.01.2018
taille1.24 Mb.
typeRapport
c.21-bal.com > comptabilité > Rapport
1   ...   14   15   16   17   18   19   20   21   22
J Am Dent Ass 2009; 140: 690-5.




  1. Napenas JJ, Oost FC, deGroot A, Loven B, Hong CH, Brennan MT, Lockhart PB, van Dierman DE. Review of postoperative bleeding risk in dental patients on antiplatelet therapy. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115: 491-9.




  1. Nematullah A, Alabousi A, Blanas N, Douketis JD, Sutherland SE. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. J Can Dent Assoc. 2009 ; 75 : 41-41i.




  1. Niamtu J. Near-fatal airway obstruction after routine implant placement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 597-600.




  1. Nizamaldin Y, Abi Najm S, El Hage M, Samson J. Hémostase locale en chirurgie orale. 1ère partie : physiologie de l’hémostase. Med Buccale Chir Buccale 2012a ; 18 : 119-127.



  1. Nizamaldin Y, Samson J. Hémostase locale en Chirurgie orale. 2ème partie : efficacité de la colle de fibrine. Med Buccale Chir Buccale 2012b ; 18 : 193-210.




  1. Oger E. Incidence of venous thromboembolism: A community-based study in western France. Epi-getbp study group. Groupe d'etude de la thrombose de bretagne occidentale. Thromb Haemost. 2000;83:657-60.




  1. Olmos-Carrasco O, Pastor-Ramos V, Espinilla-Blaco R, Ortiz-Zarate A, Garcia-Avilla I, Rodriguez-Alonso E, Herrero-Sanjuan R, Ruiz-Garcia MM, Gallego-Beuter P, Sanchez-Salgado MP, Teran-Augustin AI, Fernandez-Behar M, Pena-Sainz I. Hemorrhagic complications of dental extractions in 181 patients undergoing double antiplaqtelet therapy. J Oral Maxillofac Surg 2015 ; 73 : 203-10.




  1. Panula K, Oikarinen K. Severe hemorrhage after implant surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87 (1) :2.



  1. Patatanian E, Fugate SE. Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction. Ann Pharmacother. 2006; 40: 2205-10.




  1. Patridge CG, Campbell JH, Alvarado F. The effect of platelet-altering medications on bleeding from minor oral surgery procedures. J Oral Maxillofac Surg 2008; 66: 93-7.




  1. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, (ROCKET AF Investigators). Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-91.




  1. Park MW, Her SH, Kwon JB, Lee JB, Choi MS, Cho JS et al. Safety of dental extractions in coronary drug-eluting stenting patients without stopping multiple antiplatelet agents. Clin Cardiol 2012; 35: 225-30.




  1. Payne DA, Hayes PD, Jones CI, Belham P, Naylor AR, Goodall AH. Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. J Vasc Surg 2002; 35:1204-9.




  1. Penning-van Best FJ, van Meegen E, Rosendaal FR, Stricker BH. Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin Pharmacol Ther 2001; 69: 451-7.




  1. Pettinger TK, Owens CT. Use of low-molecular-weight heparin during dental extractions in a medicaid population. J Manag Care Pharm. 2007; 13: 53-8.




  1. Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Schved JF, de Maiste E, Samama MM, Sié P. Prise en charge des complications hémorragiques graves et de la chirurgie en urgence chez des patients recevant un anticoagulat oral anti-IIa ou anti-Xa direct. Propositions du Groupe d’Intérêt en Hémostase Périopératoire (GIHP)-mars 2013. Ann Fr Anesth Reanim 2013 ; http://dx.doi.org/10.1016/j.annfar.2013.04.016




  1. Perry DJ, Noakes TJ, Helliwell PS; British Dental Society. Guidelines for the management of patients on oral anticoagulants requiring dental surgery. Br Dent J. 2007 ; 203 : 389-93.




  1. Persac S, Boland FX, Lavis JF, Tardif A. Avulsions dentaires et anticoagulants. Rev Stomatol Chir Maxillofac. 2007 ; 108 : 189-92.




  1. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (has-bled) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey. Chest 2010;138: 1093-100.




  1. Pototski M, Amenábar JM. Dental management of patients receiving anticoagulation or antiplatelet treatment. J Oral Sci. 2007 ; 49 : 253-8.




  1. Rai R, Mohan B, Pratap Singh V, Namita, Wander GS. The risk of bleeding during dental extractions in patients receiving antiplatelet therapy. Indian J Dental Sciences 2013 ; 4 (5) : 016-018.




  1. Ramström G, Sindet-Pedersen S, Hall G, Blombäck M, Alander U. Prevention of Postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. J Oral Maxillofac Surg 1993; 51: 1211-6




  1. Rodgers RP, Levin J. A critical reappraisal of bleeding time. Semin Thromb Hemost 1990; 16: 1-20.




  1. Rossi ML, Zavalloni D, Gasparini GL, Presbitero P. Very late multivessel thrombosis of bare stents with concomitant patent drug-eluting stent after withdrawal of aspirin. Int J Cardiol 2008; 131:e7-9.




  1. Rossini R, Capodanno D. Prevalence predictors and long-term prognosis premature discontinuation of oral antiplatelet therapy after eluting stent implantation. Am J Cardiol 2011; 107: 186-94.




  1. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation (CLARITY study). N Engl J Med 2005;352:1179-89.




  1. Sacco R, Sacco M, Carpenedo M, Mannucci PM. Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different intensity targets. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 104: e18-21.




  1. Salam S, Yusuf H, Milosevic A. Bleeding after dental extractions in patients taking warfarin. Br J Oral Maxillofac Surg. 2007; 45: 463-6.




  1. Samama MM, Conard J, Lillo-Le-Louët A. Accidents hémorragiques des nouveaux anticoagulants oraux et examens de coagulation. J Mal Vasc 2013 ; 38 : 259-270.



  1. Sambu N, Warner T, Curzen N. Clopidogrel withdrawal is there a « rebound » phenomenon ? Thromb Haemost 2011; 105: 211-20.




  1. Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ. Dabigatran versus warfarin in the treatment of acute venous thromboembolism (RECOVER study). New Eng J Med 2009; 361 : 2342-52.

  2. Sié P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, van der Linden P, Pernod G, Lecompte T, Gouin-Thibault I, Albaladejo P. Chirurgies et actes invasifs chez les patients traités au long cours par un anticoagulant oral anti-Iia ou anti-Xa direct. Propositions du groupe d’intérêt en hémostase périopératoire (GIHP) et du groupe d’études sur l’hémostase et la thrombose (GEHT). Ann Fr Anesth Reanim 2011a ; 30 : 645-50.




  1. Sié P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, Van der Linden P, Pernod G, Lecompte T, Gouin-Thibault I, Albaladejo P; Working Group on Perioperative Haemostasis; French Study Group on Thrombosis and Haemostasis. Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis. Arch Cardiovasc Dis 2011b, 104 : 669-76.




  1. Siguret V, Esquirol C, debray M, Gouin I, Andreux JP, Pautas E. Surdosages en antivitamine K dans une population de patients hospitalisés âgés de plus de 70 ans. Enquête prospective sur un an. Press Med 2003 ; 32 : 972-7.




  1. Simonet V, Cambus JP, Léger P, Boneu B. Antivitamines K : utilisation pratique. Encyclopédie Médico-chirurgicale, 2003 13-022-D-50.




  1. Sindet-Pedersen S, Ramström G, Bernil S, Blombäck M. Hemostatic effect of tranexamic acid mouthwash in anticoagulant treated patients undergoing oral surgery. N Engl J Med 1989 ; 320 : 840-3.




  1. Société française d’Anesthésie et de Réanimation (Sfar). Prévention de la maladie thromboembolique veineuse périopératoire et obstétricale. Recommandations pour la pratique clinique [en ligne]. 2005: http://www.sfar.org/t/spip.php,article270




  1. Société française d’Anesthésie et de Réanimation (Sfar). Examens pré interventionnels systématiques. 13 janvier 2012.

  2. Société Francophone de Médecine Buccale et Chirurcie buccale (SFMbCb). Recommandations pour la prise en charge des patients sous agents antiplaquettaires en odontostomatologie. Med Buccale Chir Buccale 2005; 11; 2 : 55-76

.

  1. Société francophone de Médecine Buccale et Chirurcie buccale (SFMbCb). Recommandations pour la prise en charge des patients sous traitement anti-vitamines k en chirurgie bucco-dentaire. Med Buccale Chir Buccale2006; 188-212.




  1. Soto J, Sacristan JA, Fernandez-Viadero C, Verduga R. Probable acenocoumarol-amoxycillin interaction. Acta Haematol 1993; 90: 195-7.




  1. Souto JC, Oliver A, Zuazu-Jausoro I, Vives A, Fontcuberta J. oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. J Oral Maxillofac Surg 1996; 54: 27-32.




  1. Spertus JA, KettelkampR, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug—eluting stent placement. Results from the PREMIER registry. Circulation 2006; 113; 2803-9.




  1. Spolarich AE, Andrews L. An examination of the bleeding complications associated with herbal supplements, antiplatelet and anticoagulant medications. J Dent Hyg. 2007; 81: 67.




  1. Spyropoulos AC, Turpie AGG, Spandorfer J. Clinical outcomes with unfractionated heparin or low-molecular –weight heparin as bridging therapy in patients on long-term oral anticoagulants: The REGIMEN Registry. J Thromb Haemost 2006; 4:1246.




  1. Spyropoulos AG, Turpie AGG, Dunn AS. Perioperative bridging therapy with unfractionned heparin or low-molecular weight heparin as bridging therapy in patients with mechanical prosthectic heart valves on long term oral anticoagulants (from the REGIMEN registry). Am J Cardiol 2008;102:883

  2. Spyropoulos AG., To bridge or not to bridge. That is the question. The argument for bridging therapy in patients on oral anticoagulants requiring temporary interruption for elective procedure. J Thromb Thrombolysis 2010; 29:192.




  1. Sugidachi A, Ogawa T, Kurihara A, Hagihara K, Jakubowski JA, Hashimoto M, Niitsu Y, Asai F. The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite. J Thromb Haemost 2007; 5:1545-51.




  1. Todd W, Roman A. Outpatient use of Low-Molecular Weight Heparin in an anticoagulated patient requiring oral surgery : case report. J Oral Maxillofac Surg 2011; 59 : 1090-2.




  1. Václavík J, Táborský M. Antiplatelet therapy in the perioperative period. Eur J Intern Med 2011; 22: 26-31.



  1. Van Diermen D, Aartman IHA, Baart JA, Hoogstraten J, van der Waal I. Dental management of patients using antithrombotic drugs critical appraisal of existing guidelines. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: 616-24.




  1. Van Ryn J, Strangler J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, Clemens A. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010; 103: 1116-27.




  1. Verma G, Tiwari AK, Chopra S. Aspirin and exodontias: a comparative study of the bleeding complications with aspirin therapy. International Journal of Dental Science and Research 2013; 1: 50-3.




  1. Verma G. Dental extraction can be performed safely in patients on aspirin therapy: a timely reminder. ISRN Dentistry 2014, Article ID463684,http//:dx.dor.Org/10.1155/2014/463684.




  1. Vidal. Le dictionnaire. 2014; 90e edition, Issy-les-Moulineau, France. www.vidal.fr

  2. Wahl MJ. Dental surgery and anticoagulated patients. Arch Intern Med 1998; 158: 1610-6.




  1. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361: 1045-57.




  1. Wittkowsky AK. Dietary supplements, herbs and oral anticoagulants: the nature of the evidence. J Thromb Thrombolysis 2008; 25: 72-77.




  1. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357:2001-15.




  1. Wong PC, Crain EJ, Xin B, Wexler RR, Lam PY, Pinto DJ, Luettgen JM, Knabb RM. Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies. J Thromb Haemost 2008; 6:820-9.




  1. Wong PC, Pinto DJ, Zhang D. Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor. J Thromb Thrombolysis 2011;31:478-92.




  1. Wynn RL. Bleeding risks for older patients taking warfarin and commonly prescribed antibiotics and antifungals simultaneously. Gen Dent. 2012 ; 60 : 454-6.




  1. Zanon E, Martinelli F, Bacci C, Cordioli G, Girolami A. Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood coagulation & fibrinolysis 2003;14: 27-30.




  1. Zhang Q, Bal dit Sollier C, Simoneau G, Alvarez JC, Pruvot S, Aubourg R, Berge N, Bergmann JF, Mouly S, Mahé I. Ineraction between acetominophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial. Eur J Clin Pharmacol 2011; 67 : 309-14.

  2. Zhang Q, Simoneau G, Verstuyft C, Drouet L, Bal dit Sollier C, Alvarez JC, Rizzo-Padoin N, Bergmann JF, Becquemont L, Mouly S. Amoxicillin/clavulanic acid- warfarin drug interaction : a randomized controlled trial. Br J Clin Pharmacol 2011; 71: 232-36.




  1. Romond KK, Miller CS, Henry RG. Dental management considerations for a patient taking dabigatran etexilate: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116: e191-e195.




  1. Meyer G, Belmont L. Cancer and venous thromboembolism. Rev Mal Resp 2011;25:443-52.




  1. Pollack CV, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Strangier J, Steiner T, Wang B, Kam CW, Weitz JI. Idarucizumab for dabigatran reversal. New Engl J Med 2015, Jun 22.




Page |

1   ...   14   15   16   17   18   19   20   21   22

similaire:

Rapporteur iconRapporteur, ensc, Montpellier

Rapporteur iconRapporteur : Saddek Aouadi, Professeur, Université d’Annaba

Rapporteur iconRapporteur trigonométrique circulaire pour série générale et technologique...

Rapporteur iconRapporteur : Philippe Cléris Le Grand Paris et l’Eure. Ou un début...

Rapporteur iconL ycee agricole prive
«blanco», équerre, compas, rapporteur, taille-crayon, crayon à papier, double décimètre, stylos noir, bleu, vert, rouge et crayons...








Tous droits réservés. Copyright © 2016
contacts
c.21-bal.com